HSPA1A and neoplasm: Tumour growth and drug resistance are both increased in TDE-presenting Hsp70-expressing cells, whereas exosomes depletion by efflux pump inhibitors reduces extracellular Hsp70 levels and enhances chemotherapy efficacy [250].